Equities

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Actions
  • Price (EUR)10.30
  • Today's Change-0.20 / -1.90%
  • Shares traded150.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue301,965279,037266,257
OPERATING EXPENSES
Cost of revenue total123,256112,950109,671
Selling, general and admin. expenses, total91,52996,25784,499
Depreciation/amortization9,4719,5189,734
Unusual expense(income)15,02738,688(1390)
Other operating expenses, total(397)(3285)(1)
Total operating expense264,302282,425228,890
Operating income37,663(3388)37,367
Other, net(572)4.00(1)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes29,874(5799)35,616
Provision for income taxes3,1719,1848,427
Net income after taxes26,703(14983)27,189
Minority interest(60)3529
Net income before extra. Items26,643(14948)27,218
Total extraordinary items------
Net income26,643(14948)27,218
Inc.avail. to common excl. extra. Items26,634(14955)27,212
Inc.avail. to common incl. extra. Items26,634(14955)27,212
EPS RECONCILIATION
Basic/primary weighted average shares367387400
Basic/primary eps excl. extra items73(39)68
Basic/primary eps incl. extra items73(39)68
Dilution adjustment8.00--6.00
Diluted weighted average shares368387400
Diluted eps excl. extra items72(39)68
Diluted eps incl. extra items72(39)68
COMMON STOCK DIVIDENDS
DPS - common stock primary issue333232
Gross dividend - common stock12,04712,21512,805
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental831476249
SUPPLEMENTAL INCOME
Depreciation, supplemental6,4495,9865,812
Total special items15,02738,688(1390)
NORMALISED INCOME
Normalized income before taxes44,90132,88934,226
Effect of special items on income taxes1,59513,541(329)
Income tax excluding impact of special items4,76622,7258,098
Normalized income after tax40,13510,16426,128
Normalized income avail. to common40,06610,19226,151
Basic normalized EPS1092665
Diluted normalized EPS1092665
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.